NCT06410365View on ClinicalTrials.gov

Impact of Intrathecal vs Intravenous Dexmedetomidine

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions

Nausea and Vomiting, Postoperative

Interventions

DRUG

Dexmedetomidine injection

Comparison of intravenous and intrathecal route of dexmedetomidine

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Muhammad Ilyas

OTHER